Eden Research (LON:EDEN) Trading Down 3.3% – Here’s What Happened

Shares of Eden Research plc (LON:EDEN) were down 3.3% during mid-day trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The company has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The business’s fifty day moving average price is GBX 3.88 and its 200 day moving average price is GBX 3.95.

Insider Buying and Selling

In other news, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction on Tuesday, January 28th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). 14.02% of the stock is owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.